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Abstract
Direct reprogramming of human somatic cells into induced pluripotent stem (iPS) cells by defined transcription factors (TFs)
provides great potential for regenerative medicine and biomedical research. This procedure has many challenges, including
low reprogramming efficiency, many partially reprogrammed colonies, somatic coding mutations in the genome, etc. Here,
we describe a simple approach for generating fully reprogrammed human iPS cells by using a single polycistronic retroviral
vector expressing four human TFs in a single open reading frame (ORF), combined with a cocktail containing three small
molecules (Sodium butyrate, SB431542, and PD0325901). Our results demonstrate that human iPS cells generated by this
approach express human ES cells markers and exhibit pluripotency demonstrated by their abilities to differentiate into the
three germ layers in vitro and in vivo. Notably, this approach not only provides a much faster reprogramming process but
also significantly diminishes partially reprogrammed iPS cell colonies, thus facilitating efficient isolation of desired fully
reprogrammed iPS cell colonies.
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Introduction
Human embryonic stem (ES) cells have great therapeutic
potential for treatment of various diseases, but the generation of
these cells is ethically controversial. Therefore, generation of
pluripotent stem cells from somatic cells holds promise for
regenerative medicine and biomedical research [1]. Reprogram-
ming of somatic cells to pluripotent ES cell-like cells, termed
induced pluripotent stem (iPS) cells, has been achieved by the
expression of defined transcription factors (TFs), including either
the combination of Oct4, Klf4, Sox2 and c-Myc, or Oct4, Sox2,
Nanog, and Lin28 [2,3,4,5,6]. This method facilitates the
generation of patient- and disease-specific pluripotent stem cells
without immune rejection and ethical controversy that are
valuable for clinical applications.
Reprogramming human somatic cells by integrating approaches
(i.e. lentiviral or retroviral infection of defined TFs) is very
inefficient (up to 0.05%) with slow kinetics (almost 4 weeks), and
requires very high transduction efficiency [7]. Although developed
non-integrating approaches generate human iPS cells, such as
adenovirus-mediated gene delivery [8], non-integrative episomal
vectors [9,10], piggyBac transposition [11], self-excisable vector
[12], mRNAs [13], non-viral minicircle vector [14], or by the
delivery of reprogramming protein [15], the same issue is evident
in reprogramming for of iPS cell applications. Compared with
non-integrating approaches, current integrating approaches for
generating human iPS cells have much higher efficiency, and are
therefore efficacious approaches for generating human iPS cells.
Recently, rapid progress has been made towards enhancing the
efficiency of human iPSC generation by using integrating
approaches in combination with small molecules. Butyrate, a
small-chain fatty acid histone deacetylase inhibitor, greatly
enhances the efficiency of generating murine and human iPS
cells with TFs in a single or four individual vectors [16,17].
Inhibition of both TGFb and MAPK/ERK pathways using small
molecules (SB413542 and PD0325901, respectively) enhances
reprogramming of human fibroblasts with the four individual TFs
[18]. Interestingly, a combination of A-83-01 and PD0325901
generates iPS cells from neonatal human epidermal keratinocytes
by only two TFs [19]. Although these small molecules increase
efficiency of generating human iPS cells, they also require
transduction of individual TFs. Thus, there is still a tremendous
need for a safer more efficient approach for generating fully
reprogrammed human iPS cells.
Here, we describe a simple approach for generating fully
reprogrammed human iPS cells by using a single vector expressing
four TFs in a single open reading frame (ORF), in combination
with a cocktail containing three small molecules.
Our results demonstrate that human iPS cells generated by this
approach express human ES cell markers and exhibit pluripoten-
cy, as demonstrated by their abilities to differentiate into the three
germ layers in vitro and in vivo. Notably, the reprogramming
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26592process is much faster (within two weeks), the percentage of fully
reprogrammed human iPS cell colonies generated by this
approach is significantly high, and most of iPS cells generated
by our approach contain a single copy of polycistronic retroviral
vector. We provide a new alternative approach to generate full
reprogrammed human iPS cells with high efficiency.
Results
A polycistronic retroviral vector for co-expression of four
defined TFs
We previously reported generation of murine iPSC from MEFs
by using our polycistronic lentiviral vector containing the murine
KOSM fusion gene [20]. Most murine iPS colonies generated by
our system contain only one copy of viral vector leading to a
decrease of multiple proviral copies throughout the genome. When
transduced into human fibroblast cells, we found that this system
generated very few ES-like cell colonies (data not shown). We
reasoned that human TFs may increase reprogramming efficiency
in human somatic cells. Thus, we constructed a human OKSM
fusion gene with self-cleaving 2A sequences into a retroviral vector
(Figure 1A). A humanized GFP marker was cloned downstream of
the OKSM gene that was separated by an IRES to enable tracking
of transgene expression during the reprogramming process. The
self-cleaving 2A sequences derived from the foot - and – mouth
disease viruses are small and can efficiently cleave polycistrons at
specific site [21]. We and others used 2A sequences to co-express
defined TFs for generation of iPS cells [20,22,23,24].
We transfected pMIGR1-hOKSM into cells to verify that the
OKSM fusion product can be processed efficiently into individual
proteins with correct size confirmed by western blot analysis, and
to compare each protein translated from each expression vector
(Figure 1B).
Chemical compounds greatly enhance human iPSC
generation by using a single polycistronic vector
Next, we prepared retroviruses from this vector and infected
them into human fibroblasts (Figure 1C). As expected, retroviruses
carrying the hOKSM gene were efficiently transduced into human
fibroblasts, and the EGFP marker was clearly visualized by
fluorescent microscopy (Figure 1D). The fraction of infected cells
(GFP+) was 85%, as determined by flow cytometry (data not
shown). Infected and uninfected fibroblasts were harvested four
days after transduction, resuspended as a single cells, plated on
MEF feeders, and cultured as hES cells with standard hES
medium (Figure 1C). In ten individual experiments, we did not
obtain any hES cell-like colonies. Thus, this vector alone did not
efficiently generate iPS cells from human fibroblasts in conven-
tional culture medium.
Recently, it was shown that TFs-driven reprogramming of
somatic cells could be significantly enhanced by small molecules,
such as sodium butyrate [16,17], SB431542, and PD0325901 [18].
Sodium butyrate is an inhibitor of histone deacetylases, and it
increased reprogramming efficiency of both mouse and human
somatic cells [16,17]. SB431542 is a potent and selective inhibitor
of the transforming growth factor-b (TGF-b) type I receptor
activin receptor-like kinase ALK5 (IC50=94 nM), and its relatives:
ALK4 and ALK7 [25,26]. PD0325901 is a MEK inhibitor [27].
Ding and his coworkers showed that the reprogramming efficiency
of human primary fibroblasts was increased after infection with a
mixture of retroviruses expressing each TFs in combination with a
cocktail consisting of SB431542, PD0325901, and thiazovivin
[18]. Therefore, we decided to determine if the addition of three
compounds (butyrate, SB431542, and PD0325901) will promote a
reprogramming process in primary human fibroblasts infected
with pMIGR1-hOKSM (Figure 1C). We found that hES cell-like
colonies emerged from 0.29% of infected cells 15 days after viral
infection by adding butyrate alone (called one-molecule treatment)
(Figure 1D).
To study these colonies in more detail, we picked up 23 colonies
based on hES cell morphology between 15 to 23 days after
infection, and expanded them for further analysis. We first
performed alkaline phosphatase (AP) staining and then stained
these colonies with the reliable Tra-1-60 specific antibody to
monitore complete reprogramming of human somatic cells [28].
The results showed that 100% of AP-positive colonies were
positive for Tra-1-60 marker (data not shown). We also tested a
two molecule cocktail (SB431542 and PD0325901, SB+PD) and a
three molecule cocktail (sodium butyrate together with SB431542
and PD0325901, NaB+SB+PD) for reprogramming. Notably,
treatment with the three molecule cocktail (NaB+SB+PD)
significantly increased reprogramming efficiency (,3-fold) and
kinetics (12 days after infection), when compared the groups
treated with sodium butyrate alone. By using this approach, we
achieved as high as a ,0.93% reprogramming efficiency based on
the number of AP
+ colonies formed from hOKSM-infected human
fibroblasts (Figure 1C, 1D). The two-molecule treatment was less
potent than sodium butyrate, but also increased reprogramming
efficiency (,0.05%), compared to the untreated control.
In addition, we evaluated if our system would readily reprogram
other human somatic cell types: human foreskin fibroblasts (HFF-
1) and human hepatocytes. The results showed ,0.76% and
,2.38% reprogramming efficiency based on the number of AP
+
colonies formed from hOKSM-infected human hepatocytes and
HFF-1, respectively (Supplementary Table S1).
Small molecules cocktail selectively promote generation
of fully reprogrammed iPS cell colonies from human
fibroblasts transduced with retroviruses expressing
hOKSM
Because the generation of human iPS cells was dramatically
enhanced by the three molecule cocktail (Figure 1D), we asked
whether or not the small molecule cocktail could selectively
augment hOKSM to fully reprogram human fibroblasts. To address
this question, we infected human fibroblasts with retroviruses
expressing hOKSM or 4 individual human TFs (Oct4, Klf4, Sox2, c-
Myc) and treated with the three molecule cocktail at 4 days after
beingseededonfeedercells,asshownin(Figure 1C).Westained the
iPS cell colonies with the fluorescence-labeled TRA-1-60 antibody.
Figure 1E shows that although without small molecules the
percentage of TRA-1-60
+ iPS cell colonies is significantly higher
when cells were infected with retroviruses expressing 4 individual
TFs,hOKSM-expressingretrovirusesgenerated a significantlyhigher
number of TRA-1-60
+ iPS cell colonies than 4 individual TFs.
Notably, the percentage of partially reprogrammed iPS cell colonies
(TRA-1-60
2) was 4-fold lower in the group transduced withhOKSM
retroviruses than the group infected with 4 individual TFs
(Figure 1F). Together, our data indicate that combination of
hOKSM with the three molecule cocktail selectively promote
generation of fully reprogrammed iPS cell and suppressed the
growth of partially reprogrammed iPS cell colonies.
It was recently reported that NaB is much more reliable and
efficient than VPA, another histone deacetylase inhibitor, for the
generation of iPS cell colonies. Under hOKSM condition, we
compared NaB and VPA on reprogramming human fibroblasts by
infecting human fibroblasts with retroviruses expressing hOKSM,
seeding these cells on feeder cells, and culturing them in hES
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By immunofluorescence staining, we found that the effective
concentration is 0.25 and 0.5 mM for both NaB and VPA, and
that NaB was 10 and 30 times more effective than VPA at each
concentration, respectively, in the reprogramming of human
fibroblasts into iPS cells (Figure 1G).
Figure 1. Reprogramming of human adult by using a single polycistronic retroviral vector expressing four TFs combined in small
molecules. (A) Schematic representation of retroviral expression vector (pMIGR1) expressing four TFs linked via 2A sequences. Four defined human
TFs (OCT3/4, KLF4, SOX2, and c-MYC) were fused in-frame via 2A sequences and coexpressed as a single ORF (designated OKSM). The 2A-linked
cassette and GFP marker, which were separated by an internal ribosome entry site (IRES) sequence, were driven by an MSCV promoter. (B) Western-
blot analysis of four TFs from the hOKSM fusion gene. pMIGR1-hOKSM (lane 2 and 3, two clones) was transiently transfected into U2OS cells, and
expression of each TF was confirmed by immunoblotting with each corresponding antibodies. Expression plasmids (lane 4) expressing OCT3/4, KLF4,
SOX2, or c-MYC cDNA were included as positive controls; empty vector (pMIGR1, lane 1) was included as a negative control. (C) A schematic diagram
of the reprogramming protocol used. Human fibroblasts were plated at day-1 and transduced by retroviral polycistronic vector at day-0. The
transduced cells were cultured for 4 days in the FBS-containing medium used for fibroblasts, and then were harvested and counted. The single-cell
suspension was plated onto a preformed MEF monolayer. The cell media were changed the next day to hES medium with or without small molecules.
Concentrations of the small molecules used in these experiments were: NaB (sodium butyrate): 0.5 mM; SB (SB431542): 2 mM; PD (PD0325901):
0.5 mM. Emergence of colonies was monitored daily until discernible hES-like colonies were picked (days 12–23). (D) The reprogramming efficiency by
pMIGR1-hOKSM using the modified protocol with various combinations of small molecules as indicated. (E) The percentage of TRA-1-60
+ iPS cell
colonies among total colonies generated by OKSM or four individual TFs (O, Oct4; K, Klf4; S, Sox2; M, c-Myc). Human fibroblasts were infected with
pMIGR1-hOKSM or a mixture of retroviruses expressing four individual TFs, seeded on feeder cells, and then treated with the chemical compounds
(NaB, SB, and PD) as described in (C) or left without treatment. (F) The percentage of partially reprogrammed iPS cell colonies (TRA-1-60
2). (G) Total
number of iPS cell colonies (TRA-1-60
+) generated by OKSM in combination with NaB or VPA. Human fibroblasts infected with pMIGR1-hOKSM
retroviruses were seeded on feeder cells and then treated with a increasing concentration (0.25, 0.5, 1.0, and 2.0 mM) of NaB or VPA. Cell colonies
were stained with TRA-1-60-specific antibody. For all figures, the Mean and SD values were from at least two duplicates and *p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0026592.g001
Generation of Fully Reprogrammed Human iPS Cells
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26592Transgene silencing and integration during
reprogramming and karyotype analysis
The GFP marker and hOKSM fusion gene are driven by a
common CMV promoter in pMIGR1-hOKSM vector. In addition,
GFP expression should reveal expression of the hOKSM transgene.
Therefore, we examined gene-silencing of the integrated transgene
(hOKSM) during the reprogramming process by monitoring GFP
marker expression. By observing GFP expression in individual iPS
cell colonies, we found that GFP expression was almost
undetectable at 15 days for butyrate treatment (Figure 2A). To
further confirm transgene hOKSM silencing in these cell colonies,
we examined transcripts of the hOKSM transgene in each iPS cell
colony by RT-PCR. We synthesized cDNAs from total RNA
extracted from each colony and performed PCR with a pair of
specific primers for the P2A linker (Figure 1A) between the SOX2
and c-MYC sequences (Supplementary information, Table S2, for
primer sequences). As expected, RT-PCR analysis indicated that
the transcripts of hOKSM transgene were not detectable in these
iPS cell lines (Figures 2B, 2C).
Using a single polycistronic retroviral vector for reprogramming
offers a potential advantage because fewer retroviral vectors are
integrated in the genome of reprogrammed cells. Indeed, we found
that iPS cells generated from MEFs using a single polycistronic
retroviral vector contained only one retroviral integrating site [20].
Thus, we decided to determine the copy number of integrated
retroviral vectors in the generated iPS cell colonies. By splinker-
ette-PCR [29], we found that 4 of the 7 iPS cell colonies contained
only 1 copy number of integrated retroviral vector (Figure 2D).
To investigate if iPSC colonies generated using butyrate alone
and the three molecule cocktail could be stably expanded under
conventional hES culture conditions, we picked up four colonies
from butyrate treatment and three from the three molecule
cocktail treatment. All seven colonies generated in both treatments
were expanded as distinct colonies with morphology similar to
hES cells (Figure 3A), and they exhibited a normal karyotype after
being cultured for five passages by chromosomal G-band analysis
(Figure 3B).
Pluripotency of butyrate and three molecule cocktail-
treated hiPS cell lines
To further investigate if hiPS cell lines established by using our
OKSM reprogramming system combine with butyrate or three
molecule cocktail treatment, we performed immunofluorescence
staining with antibodies specific for hES cell markers and
semiquantative RT-PCR analysis. Immunostaining results showed
that all seven colonies were positive for hES cell markers: Tra-1-
60, Tra-1-81, SSEA4, OCT4, and SOX2 (Figure 4A, B). In
addition, we synthesized cDNA from iPS cell lines and confirmed
gene expression of multiple pluripotency markers in these cell
colonies by semiquantative RT-PCR analysis. The results showed
that the expression of several stem cell markers was indistinguish-
able from hES cells (Figure 4C, D).
Using embryoid body (EB) formation, we further assessed the
pluripotency of each hiPS cell line by differentiating them into the
three embryonic gem layers in vitro. By immunostaining with anti-
Tuj1 (ectoderm), anti-SMA (mesoderm), and anti-AFP (endoderm)
following EB differentiation, we showed that all iPS cell colonies
had the ability to generate all three embryonic germ layers
(Figure 5A). Finally, we assessed the pluripotency of iPS cell lines
by injecting two iPS cell lines (lines #2 and #5) into NOD-SCID
Figure 2. Silencing of transgene hOKSM during reprogramming and copy number of integrated retroviral vectors in iPS cell
colonies. (A) Images of GFP fluorescence for tracking expression of OKSM transgene during reprogramming. Scale bar, 20 mm. (B–C) RT-PCR analysis
of hOKSM transgene gene in iPS cell lines generated by one molecule (B) and three molecules (C). (D) Splinkerette-PCR analysis of retroviral
integration sites in hiPS cells. Genomic DNA was extracted from each hiPS cell line and processed for splinkerette-PCR analysis with specific primers.
The number of integrated retroviral vector is shown at bottom. M, 100 bp DNA marker.
doi:10.1371/journal.pone.0026592.g002
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derived from all three embryonic germ layers, thereby demon-
strating their pluripotency (Figure 5B).
Discussion
In the present study, we generated hiPS cells from different
human somatic cells by our new reprogramming system in a small
molecule cocktail when viral transduction efficiency was 25% (data
not shown). Notably, the ratio of fully reprogrammed iPS colonies
among AP
+ colonies was very high (,100%), as determined by
immunostaining with anti-Tra-1-60 antibodies.
The current reprogramming approaches for human iPS cells,
i.e., integrating- and non-integrating approaches, encountered
major problems: low reprogramming efficiency, slow kinetics, and
complicated procedure. For the integrating approaches of
retrovirus and lentivirus-mediated four individual TFs delivery,
the reprogramming efficiency was only ,0.01% [30,31]. Carey et
al. generated human iPS cells from neonatal human keratinocytes,
which are a potential cell source to be reprogrammed with high
reprogramming efficiency (,1%) [32], by using a single 4F2A
polycistronic lentivirus vector thereby conferring a much lower
reprogramming efficiency (,0.00001%) [22]. Similar to our initial
trials, we failed to generate human iPS cells by using our OKSM-
transgene reprogramming system alone despite documented
successful higher viral transduction. A plausible reason for the
lower efficiency is that the stoichiometry of factor expression from
the polycistronic vector is due to the 2A polycistronic vector
system support near equimolar protein expression in vivo [21],
which may be suboptimal for inducing reprogramming [22,33].
Recently, several chemicals were reported to either enhance
reprogramming efficiencies or substitute for specific reprogramming
factors, such as BIX, VPA, butyrate, SB431542, PD0325901, A83-
01, and PS48, etc [9,16,17,19,34,35]. Among these small molecules,
butyrate, a histone deacetylase inhibitor, relaxes the chromatin
structure and significantly enhances reprogramming efficiency
[16,17]. SB431542, an inhibitor of TGFb receptor, and PD0325901,
an inhibitor of MEK-ERK signaling pathway, improve the repro-
gramming efficiency of reprogrammed somatic cells infected withwith
TFs [18].Notably, combination of A-83-01 and PD0325901 generated
iPS cells from neonatal human epidermal keratinocytes by only two
TFs [19]. For the first time, we used our OKSMfusion transgene system
and demonstrated that a three compound combination (butyra-
te+SB431542+PD0325901) dramatically improved the reprogram-
ming efficiency (,0.93%), compared to either single butyrate
treatment (,0.29%) or previous reported two compound combination
(SB431542+PD0325901) (,0.05%).
Our reprogramming approach, which consists of a polycistronic
vector plus a small molecule cocktail have several important
implications.First,generationofhiPScellsbyhad a highpercentage
of full-reprogrammed iPS cells, facilitating the efficient isolation of
desired colonies. Second, although our OKSM polycistronic vector
alone did not successfully generate human iPS cells, our vector
system provides a potential platform for high-throughput screening
of novel small molecules that can enhance reprogramming process
and significantly improve generation of human iPS cells. More
Figure 3. Establishment of stable hiPS cell lines generated from human fibroblasts infected with the retroviruses containing the
hOKSM fusion gene with one or three compound treatments. (A) After reprogramming by combining transgene OKSM with small molecules,
ES-like cell colonies were individually picked and expanded by serial passages under standard culture for hES cells. Scale bars, 100 mm. (B) G-banding
karyotype analysis of iPS cell lines generated with hOKSM in combined with one and three small molecules. iPS cell line #2 and #5 reveal a normal
karyotype.
doi:10.1371/journal.pone.0026592.g003
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will facilitate discerning the reprogramming mechanisms. Third,
future studies should test whether delivering the hOKSM fusion gene
into human somatic cells via episomal vectors together with
different small molecule cocktail could efficiently reprogram human
somatic cells into human iPS cells that are not just transgene-free,
but also have less or no mutations in their genome [36,37,38].
Generation of such transgene- and mutation-free iPS cells is critical
for future clinical application.
Materials and Methods
Ethics Statement
All mouse work was conducted according to guidelines
approved by the Maine Medical Center Research Institute
Animal Care and Use Committee. This study was performed
after approval by the Maine Medical Center Research
Institute Review Board for Ethics and Safety (approval ID #
3674X).
Plasmid construction
Oct4, Klf4, Sox2, and c-Myc were amplified by polymerase chain
reaction (PCR) using Phusion
TM High-Fidelity DNA Ploymerase
(New England Biolabs), and then in-frame linked by E2A, T2A,
and P2A sequence [21], respectively, as a single open reading
frame (ORF) designated as OKSM. The OKSM fusion gene was
then cloned in pMIGR1 retroviral vector, and the resulting
plasmid was designated as pMIGR1-hOKSM. Retroviral expres-
sion vectors expressing each hTF were generated by PCR and
Figure 4. Characterization of hiPS cell lines generated from human fibroblasts using retroviruses expressing OKSM fusion gene and
one or three small molecules. (A, B) Immunofluorescence staining of pluripotency markers (TRA-1-60, TRA-1-81, SSEA4, SOX2, and OCT4) in hiPS
cell lines. Scale bar, 20 mm. (C, D) Semi-quantitative RT-PCR analysis of pluripotency markers in hiPS cell lines.
doi:10.1371/journal.pone.0026592.g004
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pMIGR1-hKlf4, pMIGR1-hSox2, and pMIGR1-hMyc.
Transfection and western blot analysis
pMIGR1-hOKSM was transfected into U2OS cells in a 24-well
plate by Fugene HD (Roche). Forty-eight hours after transfection,
the cells were washed with cold PBS and lysed with RIPA lysis
buffer plus protease inhibitor cocktail (Sigma). The cell lysates
were separated by electrophoresis on 12% SDS-polyacrylamide
gel and transferred to a nitrocellulose membrane (Pierce). The blot
was blocked with TBST (20 mM Tris-HCl, pH 7.6, 136 mM
NaCl, and 0.05% Tween-20) containing 5% non-fat milk, and
then incubated with primary antibody solution at 4uC overnight.
After washing with TBST, the membrane was incubated with
horseradish peroxidase-conjugated secondary antibody for one
hour at room temperature. The signals were detected with the
Immobilon Western Chemilumminescent horseradish peroxidase
substrate (Pierce). The list of primary antibodies is included in the
Supporting Information (Table S3).
Cell lines and cell culture
The HFF-1 and human hepatocytes were purchased from
Millipore. The primary foreskin fibroblasts’ medium was pur-
chased from Millipore. For HFF-1 and human hepatocytes, the
cells were cultured in DMEM containing 10% fetal bovine serum
(FBS), 16non-essential amino acid, 2 mM L-glutamine, and 1%
penicillin-streptomycin.
Retrovirus production
The 293T cells were plated at 8610
5 cells per 60-mm dish,
cultured overnight, and then transfected with a mixture of DNA
containing 2.5 mg of pMIGR1-hOKSM or pMIGR1 expression
vectors expressing an individual TF (or pMIGR1-hOct4, pMIGR1-
hKlf4, pMIGR1-hSox2, and pMIGR1-hMyc) and 1.5 mg of pCL-
Ampho (IMGENEX) by Fugene HD (Roche), according to the
manufacturer’s instruction. The supernatant of the transfected
cells was collected 24 hours after transfection and filtered through
a 0.45 mm pore-size filter.
Figure 5. In vitro and in vivo differentiation of a single polycistronic vector-induced hiPS cell lines with one or three compounds
treatment. (A) Micrographs of embryoid bodies (EB) generated from hiPS cel lines and in vitro differentiation. Ectodermal, mesodermal, and
endodermal cell types were revealed by antibodies specific for markers bIII-Tubulin (TUJ1), SMA, and AFP, respectively. Scale bar, 100 mm
(embryoid bodies) and 20 mm( a l lo t h e r s ) .( B) In vivo differentiation assay by teratoma formation. hiPS cells (1610
7) were injected subcutaneously
in NOD-SCID mice and teratomas were dissected after 3–8 weeks. Sections from excised tumors were stained by hematoxylin and eosin for
histology analysis. Left: squamous epithelium (ectoderm); Middle: cartilage (mesoderm); Right: glandular epithelium (endoderm). Scale bar,
20 mm.
doi:10.1371/journal.pone.0026592.g005
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Fibroblasts were seeded in a 12-well plate at 1610
4 cells per well
at one day before transduction, and incubated with the virus-
containing supernatant supplemented with 4 mg/ml polybrene
(Sigma), followed by centrifugation (900 g for 30 min). Four days
post-infection, the cells were split by using 0.025% trypsin-EDTA
and plated on MEF feeder cultured in fibroblast medium. After
24 hours, the medium was switched to the human reprogramming
medium (DMEM/F12, 20% knockout serum replacement, 16
non-essential amino acid, 2 mM L-glutamine, 0.1 mM 2-mercap-
toethanol, 20 ng/ml FGF-2 and 1% penicillin-streptomycin), and
treated with 0.5 mM sodium butyrate (Sigma), 2 mM SB431542
(Stemgent), and 0.5 mM PD0325901 (Stemgent) or other combi-
nations of the compounds. The media were changed every other
day until the induced colonies were picked up based on human ES
cell colony morphology at days 20–23 post-infection. The GFP
ratio was determined by flow cytometry at day-4 after viral
infection. The individual ES cell-like colony was monitored for
GFP marker expression during reprogramming.
Immunofluorescent staining
The cells were fixed in 4% paraformaldehyde for 20 min at
room temperature, washed three times with PBS, and blocked for
30 min with 5% FBS in PBS containing 0.05% Triton X-100,
followed by incubation with primary and second antibodies. The
antibodies were diluted in 1% FBS in PBS containing 0.05%
Triton X-100. The list of primary antibodies is included in the
Supporting Information (Table S3).
Extraction of genomic DNA and RNA and RT-PCR
The genomic DNA was extracted by using QIAamp DNA Mini
kit (Qiagen). All of the RNA was extracted by using Quick-
RNA
TM MicroPrep kit (Zymo Research). All of the RNA (200 ng)
was used to synthesize cDNA using SuperScript III First-Strand
Sunthesis SuperMix kit (Invitrogen), according to the manufac-
turer’s instructions. PCR was performed with gene-specific
primers. The list of primers is included in the Supporting
Information (Table S2 and S3).
Determination of retroviral integration sites by
splinkerette-PCR
The retroviral integration sites in the hiPS cell lines were
determined by splinkerette-PCR according to the previously
reported method [29]. Briefly, genomic DNA (2 mg) was isolated
from hiPS cells using Quick-gDNA MiniPrep Kit (ZYMO
RESEARCH), and completely digested with Sau3A I restriction
enzyme at 37uC overnight. The fragments were ligated with
splinkerette-adaptor mixture by T4 DNA ligase (New England
Biolabs) at 4uC overnight. The adaptor-ligated splinkerette
products were digested with Mse I for 6 hours at 37uC and then
purified by QIAquick Gel Extraction Kit (QIAGEN) according to
the manufacturer’s instructions. The purified products were
processed for primary PCR amplification by the primary primers
Splink-F1 and 59LTR-R1. A secondary PCR was then carried out
on 1 ml of the primary PCR product with the primers Splink-F2
and 59-LTR-R2. The resulting PCR products were run on a 4%
agarose gel. The sequences for each primer are included in the
Supporting Information (Table S2 and S3).
Karyotype analysis
The cells were cultured for 24 hours in a CO2 incubator, and
treated with colcemid acid (0.1 mg/ml, final concentration) for one
hour before harvesting. The cells were washed with PBS,
transferred into 15 ml tubes, and then centrifuged for 10 min at
250 g. The supernatant was removed and resuspended in 10 ml
KCl (75 mM). The cell mixtures were incubated for 30 min in
37uC water bath and then fixed by adding 2 ml of fixative solution
(methanol/acetic acid 3:1). The fixed cells were washed at least
twice with 10 ml of fixative solution before being applied onto
chilled slides. The slides with chromosomes were dried and treated
with 0.025% trypsin for 5 min and stained with KaryoMAX
Giemsa Stain solution (Invitrogen) for 5 min.
Calculation of reprogramming efficiency
We quantified infected cells (GFP
+) at day-4 post-infection and
counted the ES cell-like cell colonies, AP
+ colonies, and Tra-1-60
+
colonies after reprogramming. Reprogramming efficiency was
determined by the total number of true pluripotent iPS cell
colonies divided by the total number of infected cells (GFP
+).
In vitro differentiation of iPS cells
For EB formation, human iPS cells were expanded and
harvested by treatment with Collagenase IV (STEMCELL). The
clumps of the cells were transferred to ultra-low attachment plate
in DMEM/F12 containing 20% knockout serum replacement,
16 non-essential amino acid, 2 mM L-glutamine, 0.1 mM 2-
mercaptoethanol and 1% penicillin-streptomycin. The medium
was changed every other day. After eight days, the EBs were
placed in pre-condition culture for 2–3 days and maintained in
three different differentiation medium in ultra-low attachment
plates. For endoderm differentiation, the EBs were cultured in the
presence of KO-DMEM medium supplemented with 10% FBS,
2 mM L-gultamine, 0.1 mM 2-mercaptoethanol, 16 non-essen-
tial amino acids, and 1% penicillin-streptomycin. For mesoderm
differentiation, we used the same medium described above, and
added ascorbic acid (0.5 mM). For ectoderm induction, the EBs
were cultured in N2/B27 medium (Invitrogen). After the
precondition step, the EBs were transferred to a 0.1% gelatin-
coated plate and cultured in differentiation medium for two
weeks. The medium for each condition was changed every other
day.
Teratoma formation assay
All mouse procedures were conducted in compliance with
institutional animal use guidelines. The human iPS cells were
collected from MEF feeder by Accutase (Millipore), washed three
times with cold PBS, and then resuspended in PBS supplemented
with 50% Matrigel (BD Biosciences). The cell mixtures were kept
on ice and drawn into 1-ml syringe immediately before injection.
Approximately 5610
6 cells in 200 ml per injection site were used.
NOD/SCID mice were injected in the dorsolateral area into the
subcutaneous space on both sides. The tumors were dissected from
mice 8–10 weeks after injection, fixed in 4% formaldehyde, and
then embedded in paraffin. The paraffin section were processed
and stained with hematoxylin and eosin.
Supporting Information
Table S1 Estimation of reprogramming efficiency.
(DOC)
Table S2 List of primers for qPCR.
(DOC)
Table S3 List of antibodies for immunofluorescence
staining and western blot.
(DOC)
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